DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

BALAXI PHARMACEUTICALS LIMITED — Updates

NSE 3 hrs ago·7 Aug 2026, 4:35 pm

Balaxi Pharma

Balaxi Pharmaceuticals has informed stock exchanges about its 'RTA Report for Re-lodgement of Transfer Requests of Physical Shares' for the period ending July 2026. This document details the progress of physical share certificates that have been sent back to the company's Registrar and Transfer Agent for processing.

This update is a routine corporate filing that investors monitor to ensure the smooth transfer of ownership for physical share certificates. It confirms the company's ongoing efforts to manage share transfers and maintain an accurate shareholder register.

Investors should watch for the finalised report to confirm the successful processing of these transfer requests. This ensures that shareholding details are updated in the company's records, which is essential for maintaining ownership rights.